Browse by author
Lookup NU author(s): Dr Ashwin Sivaharan, Dr Muhammad Kanani, James McCaslin, Dr Sandip Nandhra, Karen Booth
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
© 2021Objective: The COVID-19 pandemic has forced the cancellation of planned surgery and led to significant surgical service reductions. Early intervention in aortovascular disease is often critical and cannot be deferred despite these reductions. There is urgent need to evaluate the provision and outcomes of thoracic aortovascular intervention during the peak of the pandemic. Methods: Prospective data was collected for patients receiving open and endovascular thoracic aortovascular intervention over two-time points; January-May 2020 and January-May 2019 at three tertiary cardiovascular centres. Baseline demographics, cardiovascular risk and COVID-19 screening results were noted. Primary outcomes were median length of intensive care unit and hospital stay, intra-operative mortality, 30-day mortality, post-operative stroke, and spinal cord injury. Results: Patients operated in 2020 (41) had significantly higher median EuroSCORE II than 2019 (53) (7.44 vs. 5.86, P = 0.032) and rates of previous cardiac (19.5% vs. 3.8%, P = 0.019), aortic (14.6% vs. 1.9%, P = 0.041), and endovascular (22.0% vs. 3.8%, P = 0.009) intervention. There was an increase in proportion of urgent cases in 2020 (31.7% vs. 18.9%). There were no intra-operative deaths in 2020 and 1 in 2019 (P = 1.00). There were no significant differences (P ≥ 0.05) in 30-day mortality (4.9% vs. 13.2%), median intensive care unit length of stay (72 vs. 70 hr), median hospital length of stay (8 vs. 9 days), post-operative stroke (3 vs. 6), or spinal cord injury (2 vs. 1) between 2020 and 2019 respectively. Conclusions: Despite the increased mortality risk of patients and urgency of cases during COVID-19, complicated by the introduction of cohorting and screening regimens, thoracic aortovascular intervention remained safe with comparable in outcomes to pre-COVID-19.
Author(s): McPherson I, Chilvers N, Freystaetter K, Sivaharan A, Kanani M, Williams R, McCaslin J, Nandhra S, Booth K
Publication type: Article
Publication status: Published
Journal: Annals of Vascular Surgery
Year: 2021
Volume: 75
Pages: 120-127
Print publication date: 01/08/2021
Online publication date: 24/04/2021
Acceptance date: 13/04/2021
ISSN (print): 0890-5096
ISSN (electronic): 1615-5947
Publisher: Elsevier Inc.
URL: https://doi.org/10.1016/j.avsg.2021.04.008
DOI: 10.1016/j.avsg.2021.04.008
PubMed id: 33905848
Altmetrics provided by Altmetric
